0001363585-12-000012.txt : 20120705 0001363585-12-000012.hdr.sgml : 20120704 20120705163437 ACCESSION NUMBER: 0001363585-12-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120703 FILED AS OF DATE: 20120705 DATE AS OF CHANGE: 20120705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Masterson Nola E CENTRAL INDEX KEY: 0001305231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 12948593 MAIL ADDRESS: STREET 1: 177 POST STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-07-03 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001305231 Masterson Nola E 33 HARBOUR SQUARE SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 1 0 0 0 Common Stock 2012-07-03 4 M 0 508197 0.001 A 508197 D Common Stock Purchase Option (right to buy) 0.001 2012-07-03 4 M 0 508197 0 D 2012-06-19 2017-06-19 Common Stock 508197 0 D On June 6, 2012, the Board of Directors of the issuer granted the reporting person options to purchase 508,197 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 19, 2012. The grant was made pursuant to the terms of the issuer's 2006 stock plan. Nola E. Masterson 2012-07-05